viernes, 22 de septiembre de 2017

Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception among Women at High Risk for HIV

Division of Reproductive Health Global Activity eUpdate

Update to CDC’s U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Revised Recommendations for the Use of Hormonal Contraception among Women at High Risk for HIV

USMEC
As an update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (US MEC), CDC is revising its recommendations on the use of hormonal contraceptives among women at high risk for HIV, based on new scientific evidence.  
Use of the progestin-only injectable contraceptive depot medroxyprogesterone acetate (DMPA) by women at high risk for HIV has been changed from a US MEC Category 1 (no restriction) to Category 2 (benefits outweigh theoretical or proven risks). An accompanying updated clarification states that while there is evidence of a possible increased risk of acquiring HIV among progestin-only injectable users, it is not clear whether this is due to methodological issues with the evidence or a real biological effect.  
Women should not be denied the use of DMPA because of concerns about a possible increased risk, but should be counseled about these concerns and about how to reduce their risk of acquiring HIV.  
Recommendations for the other hormonal contraceptive methods reviewed (implants, combined hormonal pills, patches, rings, and progestin-only pills) remain the same; there is no restriction for their use among women at high risk for HIV (US MEC Category 1).
All women at risk for HIV infection – regardless of their contraceptive choice – should be counseled about how to reduce their risk of acquiring HIV, including limiting number of sexual partners, correct and consistent condom use, and consideration of pre-exposure and post-exposure prophylaxis. 

Dr. Ted Trimble: Why I Do Cancer Research, World Cancer Research Day 2017



09/22/2017 10:13 AM EDT
Dr. Ted Trimble, Director of the National Cancer Institute's Center for Global Health, shares why he has committed his career to cancer research, and why global research and partnerships are key to accelerating progress against cancer. World Cancer Research Day, September 24, 2017, is a day of recognition for the critical cancer research being done around the world. www.cancer.gov/about-nci/organization/cgh/blog/2017/cancer-research-day

Dr. Ted Trimble: Why I Do Cancer Research, World Cancer Research Day 2017



09/22/2017 10:13 AM EDT
Dr. Ted Trimble, Director of the National Cancer Institute's Center for Global Health, shares why he has committed his career to cancer research, and why global research and partnerships are key to accelerating progress against cancer. World Cancer Research Day, September 24, 2017, is a day of recognition for the critical cancer research being done around the world. www.cancer.gov/about-nci/organization/cgh/blog/2017/cancer-research-day

Free CME: Injection Safety: A System-Wide Approach

Improving Injection Safety through a System-Wide Approach


Please watch and share this new free continuing education opportunity on the importance of implementing a system-wide approach to prevent safety risks associated with incorrect use of injectable medications. You’ll increase your knowledge regarding:
  • Injection Safety: A System Approach System-wide processes, procedures, or situations to improve injection safety 
  • Infection transmission risks associated with healthcare provider narcotic diversion behavior
  • Strategies to mitigate these risks
This is the final part of a six-part series from the Centers for Disease Control and Prevention and Medscape addressing the key issues surrounding infection prevention in healthcare facilities.
Series topics include:
  1. Risk Recognition in Healthcare Settings (Available Now)
  2. Environmental Services and Infection Prevention (Available Now)
  3. Recognizing Infection Risks in Medical Equipment (Available Now)
  4. Infection Transmission Risks Associated with Nonsterile Glove Use (Available Now)
  5. Infection Prevention: A Hierarchy of Controls Approach (Available Now)
  6. Injection Safety: A System Approach (Available Now)
Medscape registration is free and easy and you must be a registered Medscape member to access these CME/CE activities.

EL BIRUNI: CIENCIAS MÉDICAS NEWS [https://elbiruniblogspotcom.blogspot.com.ar] ▲ DIRECTORIO DE DOCUMENTOS EDITADOS EN SEPTIEMBRE de 2017 [*] ► Contenidos Copyright by Cerasale Morteo, Víctor Norberto; 2008 a 2017. SALTA / ARGENTINA. 22 de SEPTIEMBRE de 2017 [09/00117]

EL BIRUNI: CIENCIAS MÉDICAS NEWS [https://elbiruniblogspotcom.blogspot.com.ar DIRECTORIO DE DOCUMENTOS EDITADOS EN SEPTIEMBRE de 2017 [*]  Contenidos Copyright by Cerasale Morteo, Víctor Norberto; 2008 a 2017. SALTA / ARGENTINA. 22 de SEPTIEMBRE de 2017 [09/00117]

https://elbiruniblogspotcom.blogspot.com.ar
EL BIRUNI: CIENCIAS MÉDICAS NEWS  DIRECTORIO DE DOCUMENTOS EDITADOS EN SEPTIEMBRE de 2017 [*]  Contenidos Copyright by Cerasale Morteo, Víctor Norberto; 2008 a 2017. SALTA / ARGENTINA.

[09/00117/2017]

ARCHIVO DEL BLOG

 ARCHIVO DEL BLOG


ARCHIVO DEL BLOG


ARCHIVO DEL BLOG


ARCHIVO DEL BLOG




ARCHIVO DEL BLOG


 ARCHIVO DEL BLOG


 ARCHIVO DEL BLOG




ARCHIVO DEL BLOG



NUESTRA SEÑORA DE LA MEDALLA MILAGROSA

NUESTRA SEÑORA DE LA MEDALLA MILAGROSA
guía y luz a lo largo de mi vida